Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands

C Boersma, R Klok, J Bos, Mark Naunton, P Van Den Berg, L Dejong-Van den Berg, M Postma

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)191-196
    Number of pages6
    JournalApplied Health Economics and Health Policy
    Volume4
    Issue number3
    Publication statusPublished - 2005

    Cite this

    Boersma, C., Klok, R., Bos, J., Naunton, M., Van Den Berg, P., Dejong-Van den Berg, L., & Postma, M. (2005). Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands. Applied Health Economics and Health Policy, 4(3), 191-196.